Therefore, extensive surgical tumor removal is essential to improve the prognosis of patients with WHO grade III gliomas, especially for astrocytic tumors with the IDH1/2 mutation lacking the 1p/19q co-deletion. Here, IDH1 is linked to central nervous system cancer.